Treatment of Multifocal Lung Adenocarcinoma (NCT01946100) | Clinical Trial Compass
TerminatedNot Applicable
Treatment of Multifocal Lung Adenocarcinoma
Stopped: Funding ended prior to completion of enrollment.
United States100 participantsStarted 2013-11-06
Plain-language summary
To gather preliminary safety and outcome data for the multimodality treatment of lung adenocarcinoma in the setting of multifocal BAC.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
* Patient must be \> 18 years of age
* Two or more GGO's or solid lesions suspicious for multifocal disease.
* Clinical diagnosis of N0
* No evidence of distant metastases
* No prior intra-thoracic radiation therapy (NOTE: Previous radiotherapy as part of treatment for head and neck, breast, or other non-thoracic cancer is permitted.), previous chemotherapy, or surgical resection for non-small cell lung cancer (NSCLC).
* No other cancer in the past 5 years except early stage prostate cancer, or basal cell of skin.
* PFT's that show patient is capable of tolerating a lung resection.
* Non-pregnant and non-lactating. Women of child-bearing potential must have a negative urine or serum pregnancy test to participate in the study.
* Patient must be able to understand and willing to sign an IRB-approved informed consent document.